MX9301393A - Tratamiento de migraña. - Google Patents

Tratamiento de migraña.

Info

Publication number
MX9301393A
MX9301393A MX9301393A MX9301393A MX9301393A MX 9301393 A MX9301393 A MX 9301393A MX 9301393 A MX9301393 A MX 9301393A MX 9301393 A MX9301393 A MX 9301393A MX 9301393 A MX9301393 A MX 9301393A
Authority
MX
Mexico
Prior art keywords
blocking agent
migraine treatment
administered
migraine
relates
Prior art date
Application number
MX9301393A
Other languages
English (en)
Inventor
Arthur M Goldberg
Leonard Lachman
Original Assignee
Rugby Darby Group Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rugby Darby Group Co Inc filed Critical Rugby Darby Group Co Inc
Publication of MX9301393A publication Critical patent/MX9301393A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Disintegrating Or Milling (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Catalysts (AREA)

Abstract

Esta invención se relaciona con un método para tratar dolores de cabeza de migraña clásica. De acuerdo con este método, una cantidad terapéutica de un agente bloqueador ß adrenérgico se administra a una persona que sufre un ataque de migraña pronto ante el inicio del aura.
MX9301393A 1992-03-13 1993-03-12 Tratamiento de migraña. MX9301393A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/850,566 US5242949A (en) 1992-03-13 1992-03-13 Treating classic migraine

Publications (1)

Publication Number Publication Date
MX9301393A true MX9301393A (es) 1994-08-31

Family

ID=25308498

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301393A MX9301393A (es) 1992-03-13 1993-03-12 Tratamiento de migraña.

Country Status (18)

Country Link
US (1) US5242949A (es)
EP (1) EP0727986B1 (es)
JP (1) JP2839207B2 (es)
KR (1) KR950701215A (es)
AT (1) ATE193441T1 (es)
AU (1) AU675931B2 (es)
CA (1) CA2131991C (es)
DE (1) DE69328792T2 (es)
DK (1) DK0727986T3 (es)
ES (1) ES2148222T3 (es)
FI (1) FI944236A (es)
GR (1) GR3034188T3 (es)
HU (1) HUT71834A (es)
MX (1) MX9301393A (es)
NO (1) NO943372L (es)
PH (1) PH30101A (es)
PT (1) PT727986E (es)
WO (1) WO1993017672A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408026A (en) * 1993-08-23 1995-04-18 Cowan; Patrick J. Curable and cured organosilicon compositions, and process for making same
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US20080226715A1 (en) * 2007-03-16 2008-09-18 Albert Cha Therapeutic compositions and methods
WO2009103150A1 (en) * 2008-02-20 2009-08-27 Kevin David Smith Method for treating migraine headaches
US9399053B2 (en) 2011-07-22 2016-07-26 The University Of Chicago Treatments for migraine and related disorders
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394390A (en) * 1979-08-03 1983-07-19 University Of Kentucky Research Foundation Nasal dosage forms of propranol
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same

Also Published As

Publication number Publication date
HU9402612D0 (en) 1994-11-28
PT727986E (pt) 2000-11-30
JPH08500329A (ja) 1996-01-16
DE69328792D1 (de) 2000-07-06
DE69328792T2 (de) 2001-02-01
HUT71834A (en) 1996-02-28
ATE193441T1 (de) 2000-06-15
CA2131991C (en) 1999-07-06
FI944236A0 (fi) 1994-09-13
NO943372L (no) 1994-11-14
DK0727986T3 (da) 2000-10-30
EP0727986A4 (en) 1995-04-25
PH30101A (en) 1996-12-27
EP0727986B1 (en) 2000-05-31
KR950701215A (ko) 1995-03-23
WO1993017672A1 (en) 1993-09-16
NO943372D0 (no) 1994-09-12
FI944236A (fi) 1994-11-11
US5242949A (en) 1993-09-07
EP0727986A1 (en) 1996-08-28
AU3799193A (en) 1993-10-05
GR3034188T3 (en) 2000-11-30
ES2148222T3 (es) 2000-10-16
AU675931B2 (en) 1997-02-27
CA2131991A1 (en) 1993-09-16
JP2839207B2 (ja) 1998-12-16

Similar Documents

Publication Publication Date Title
TW200607512A (en) Use of optically pure (S,S)-reboxetine in the manufacture of a medicament for the treatment or prevention of migraine headaches
BG100960A (en) Dosage forms for controlled release of azitromycin
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
MX9301393A (es) Tratamiento de migraña.
SE9601395D0 (sv) New therapeutic treatment 1
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
ATE293972T1 (de) Behandlung von chronischen schmerzen
DK1077683T3 (da) Antidepressiv behandling
NO962221L (no) Anvendelse av dimeticon for behandling av konstipasjon
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
PL349889A1 (en) Method for treatment of headache
NO984198L (no) FremgangsmÕte for behandling av aggresjon
NO984190L (no) FremgangsmÕte for behandling av insomnia
PT1304107E (pt) Utilizacao de derivados de oxazolidininas para o tratamento da psoriase
NO981020D0 (no) Transdermalt terapautisk system for silatranforbindelser
RU96114051A (ru) Способ лечения экземы у травматолого-ортопедических больных с гнойной инфекцией
UA10257A (uk) Спосіб фізіотерапевтичного впливу на організм людини
UA8280A (uk) Спосіб лікування псоріазу
UA50329A (uk) Спосіб лікування первинної бешихи

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees